Breaking News
Top News
-
PTC Therapeutics (PTCT) Reports Positive Huntington’s Disease Trial Results
-
Corcept (CORT) Upgraded After Key Regulatory Approval for Lifyorli
-
Arrowhead (ARWR) Rated Buy on Metabolic Pipeline Potential
-
Genmab (GMAB) Rated Outperform on Oncology Pipeline
-
Incyte (INCY) Positioned to Offset Patent Cliff Risks, Analysts Reaffirm Stock Ratings
-
Argenx (ARGX) Outlook Improves on Autoimmune Pipeline Expansion
-
Halozyme (HALO) Rated Buy on Strong Royalty Growth
-
ACADIA (ACAD) Upgraded to Buy After Recent Pullback
-
Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending
-
Missed Advanced Micro Devices’ Big Move? Here’s Why It’s Still a Buy
-
Is Loar Holdings Inc. (LOAR) A Good Stock To Buy Now?
-
Is Exxon Mobil Corporation (XOM) A Good Stock To Buy Now?
-
Elon Musk’s SpaceX Could Be Fast-Tracked Into S&P 500 After IPO Under Proposed Rule Changes
-
Is RadNet, Inc. (RDNT) A Good Stock To Buy Now?
-
Is AXT, Inc. (AXTI) A Good Stock To Buy Now?
-
Is Waste Management, Inc. (WM) A Good Stock To Buy Now?
-
Is Visa Inc. (V) A Good Stock To Buy Now?
-
Donald Trump endorsed this stock and the market reacted
-
Is MongoDB, Inc. (MDB) A Good Stock To Buy Now?
-
Is Zeta Global Holdings Corp. (ZETA) A Good Stock To Buy Now?
2026-02-05







